캘리포니아의 신경교종 임상 시험
신경교종 관련 연구 27개가 캘리포니아 내 여러 지역에서 참여자를 모집하고 있습니다.
캘리포니아의 도시
공식 연구 텍스트(영어)
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- UCSD Moores Cancer Center, La Jolla
- Cedars-Sinai Medical Center, Los Angeles
- UC Irvine Health, Orange
- 외 1개
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT07326566A Phase I Clinical Study of YN003 in the Treatment of Glioma
- University of California, Los Angeles (UCLA), Los Angeles
- University of California, San Francisco (UCSF), San Francisco
피험자 모집 중1상
18세 ~ 70세 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT07929909Safety and Efficacy Study of Safusidenib in Participants With IDH1-Mutant Glioma Who Discontinued Vorasidenib Treatment Due to Progressive Disease
- University of California, Los Angeles, Los Angeles
- University of California, San Francisco, San Francisco
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT07703436A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma
- Stanford University, Palo Alto
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07464925A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With a Tumour in the Brain That is Positive for DLL3
- University of California Irvine, Orange
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 27. 업데이트됨 · NCT05916313Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- University of California, Irvine, Irvine
- University of California Los Angeles, Los Angeles
- University of California at San Francisco, San Francisco
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 21. 업데이트됨 · NCT06810544SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- University of California San Diego, La Jolla
- University of California, Los Angeles, Los Angeles
- Hoag Memorial Hospital Presbyterian, Newport Beach
- 외 2개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 10. 19. 업데이트됨 · NCT05303519Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
- Research Site, Los Angeles
- Research Site, San Francisco
피험자 모집 중1/2상
18세 ~ 130세 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT05417594MCT for the Harvard/UCSF ROBIN Center
- University of California, San Francisco, San Francisco
피험자 모집 중
전 연령 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT06000787A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- Children's Hospital Los Angeles, Los Angeles
- University of California at Los Angeles, Los Angeles
피험자 모집 중1/2상
25세 이하 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT04094610Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma
- Cedars-Sinai Medical Center, Los Angeles
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 21. 업데이트됨 · NCT04977375A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors
- Children's Hospital Orange County (CHOC), Orange
피험자 모집 중1상
5세 ~ 18세 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT06357377Assessing Brain Metabolism Using MRS With Deuterated Glucose
- University of California, San Francisco, San Francisco
피험자 모집 중관찰 연구건강한 지원자 환영
18세 이상 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT06594315Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
- Children's Hospital Los Angeles, Los Angeles
- University of California, San Diego Rady Children's Hospital, San Diego
- University of California, San Francisco, San Francisco
피험자 모집 중1상
1세 ~ 25세 · 모든 성별 · 2026. 8. 18. 업데이트됨 · NCT04485559Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
- UCI Irvine Health, Orange
피험자 모집 중4상
18세 이상 · 모든 성별 · 2026. 8. 11. 업데이트됨 · NCT07486713Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
피험자 모집 중초기 1상
18세 이상 · 모든 성별 · 2026. 7. 31. 업데이트됨 · NCT07628634A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Precision NextGen Oncology & Research Center, Beverly Hills
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
- University of California Los Angeles Rheumatology, Westwood, Los Angeles
피험자 모집 중2상
8세 이상 · 모든 성별 · 2026. 7. 27. 업데이트됨 · NCT05503797Imaging of Solid Tumors Using 18F-TRX
- University of California, San Francisco, San Francisco
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 7. 23. 업데이트됨 · NCT06942104Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- Stanford University School of Medicine, Palo Alto
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 6. 29. 업데이트됨 · NCT03510208Hyperpolarized Imaging in Diagnosing Participants With Glioma
- University of California, San Francisco, San Francisco
피험자 모집 중1상
19세 이상 · 모든 성별 · 2026. 6. 18. 업데이트됨 · NCT03739411Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT Patients
- Moores Cancer Center, San Diego
피험자 모집 중관찰 연구
18세 ~ 99세 · 모든 성별 · 2026. 6. 10. 업데이트됨 · NCT05576103Serial MR Imaging and MR Spectroscopic Imaging for the Characterization of Lower Grade Glioma
- University of California, San Francisco, San Francisco
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 4. 29. 업데이트됨 · NCT04540107A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
- UCLA Hematology/Oncology, Westwood, Los Angeles
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 4. 20. 업데이트됨 · NCT06326411rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG
- Children's Health Orange County (CHOC), Orange
피험자 모집 중1상
12 Months – 18 Years · 모든 성별 · 2026. 3. 17. 업데이트됨 · NCT04943848DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma
- University of Southern California, Los Angeles
- University of California, San Diego, San Diego
- University of California, San Francisco
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 3. 11. 업데이트됨 · NCT06504381Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 2. 5. 업데이트됨 · NCT06650163The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
- University of California, San Francisco (UCSF), San Francisco
피험자 모집 중관찰 연구
18세 ~ 90세 · 모든 성별 · 2024. 2. 22. 업데이트됨 · NCT06118723ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.